StockData

Dyadic International vs Eloxx Pharmaceuticals

DYAI and ELOX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DYAI and ELOX compare

Eloxx Pharmaceuticals is the larger company, worth 4.1 times as much as Dyadic International ($47.4M against $11.5M).

Dyadic International grew revenue faster over the last twelve months (−7.6% versus −100% for Eloxx Pharmaceuticals).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDYAIELOX
Size and price
Market cap$11.5M$47.4M
Share price$0.316$11.74
Change, 1 year−65.4%1067170%
Change, 5 years−91.5%−98.1%
Beta (5Y)1.46–
Employees57
StockData Score
Total score77
Valuation score11
Growth score00
Performance score11
Health score55
Dividend score00
Valuation
P/S3.7×–
P/B–1.0×
Growth
Revenue growth (TTM)−7.6% (better)−100%
Revenue growth, 5Y average14.0%–
Profitability
Gross margin17.9%–
Operating margin−237%–
Net margin−227%–
Return on equity−47256%−54.3% (better)
Financial health
Debt / equity–0.00
Current ratio1.693.74 (better)
Altman Z-score−18.96−4.60 (better)
Piotroski F-score23 (better)
Dividends and buybacks
Buyback yield–0.00%
Shareholder yield0.00%0.00%
Ownership
Held by institutions12.7%71.8%
Held by insiders28.0%42.6%
Insider net buying, 12 months−$125K–
Short interest, % of float0.32%2.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.